Skip to main content

PR: Heidelberg Pharma reports on the results of the Annual General Meeting 2023

Ladenburg, Germany, 25 May 2023 - Heidelberg Pharma AG (FSE: HPHA) announced that the company's shareholders approved the following proposed resolutions of the management with a large majority (between 96,30 % and 99,99 %) at today's ordinary virtual Annual General Meeting:

  • Discharge of the members of the Management Board and the Supervisory Board for the fiscal year 2022
  • Appointment of the auditors and group auditors for fiscal year 2022/2023
  • Election of a new Supervisory Board member
  • Amendments to the Articles of Association relating to the holding of a virtual Annual General Meeting, the virtual participation of Supervisory Board members and the quorum of the Supervisory Board
  • Authorization to grant subscription rights (Heidelberg Pharma Stock Option Plan 2023), reduction of individual Conditional Capitals, creation of a Conditional Capital 2023/I, and corresponding amendments to the Articles of Association
  • Approval of the remuneration report

Attendance (incl. postal votes cast) at the Annual General Meeting 2023 corresponded to 84,24 % of the current capital stock.

For more information on the Annual General Meeting, including the voting results, please visit: